Changes to therapy

As time goes on, your CML treatment plan may change - and that’s completely normal. Adjusting therapy is often about fine‑tuning what works best for you.

In this series, Dr Guy Hannah explains when a dose might be reduced and how response is carefully monitored. Dr Kate Rothwell discusses when treatment can be safely stopped for some patients, and what that process involves.

Dr Hugues de Lavallade outlines what happens if you need to switch to a different TKI, or when a stem cell transplant might be considered.

Finally, Dr Ali Mahdi explores the role of clinical trials and how they help shape future treatment options.

These videos are designed to give you confidence in understanding how and why changes may happen, and to highlight the expert care guiding every step of your CML journey.